Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Scancell and ImmunID to use ImmunTraCkeR to predict response to SCIB-1

July 31, 2015

FDA clears KaloBios' IND for KB-003 for chronic myelomonocytic leukemia

July 30, 2015

Inovio Pharmaceuticals begins trial of INO-5150 for prostate cancer

July 30, 2015

Fujifilm Kyowa Kirin Biologics establishes joint venture with AstraZeneca

July 29, 2015

Horizon collaborates with Fox Chase to study Actimmune with PD-1/PD-L1 inhibitors for cancer

July 29, 2015

TapImmune exercises option agreement for folate receptor alpha vaccine technology

July 28, 2015

EMA grants accelerated assessment to MAA for elotuzumab in MM

July 28, 2015

Inovio and EORTC to conduct phase II trial of INO-3112 in cervical cancer

July 24, 2015

Novartis files sBLA for ofatumumab as maintenance therapy for relapsed CLL

July 23, 2015

Merck & Co.'s Keytruda approved in Europe for advanced melanoma

July 23, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....